Monthly Archives: April 2013

Another trial of darbepoetin alfa (Aranesp) shows disappointing results

In 2009 TREAT, a large placebo-controlled trial of darbepoetin alfa, an erythropoiesis stimulating agent (ESA) was conducted in patients with type 2 diabetes who had chronic kidney disease and anemia (see TREAT).  The rationale for the study was that CKD … Continue reading

Posted in M Loghman-Adham, MD | Leave a comment